| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.038 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |